Sobi publishes Q1 2023 report: Continued solid progress
STOCKHOLM, April 27, 2023 /PRNewswire/ -- Swedish Orphan Biovitrum AB (publ) (Sobi®) today announced its report for the first quarter of 2023 First quarter 2023 Total revenue SEK 5,239 M (4,925), +6 per cent, -2 per cent at constant exchange rates (CER).i Haematology revenue SEK 2,815 M...
Read more »